Company / Interest Expense per Share
AVADEL PHARMACEUTICALS PLC Interest Expense per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.11
FY2024
5-year range
$0.11 / $0.24
FY2020-FY2024
Trend
-7.7%
vs FY2023
Sector context
#22 of 43
Health Care
What the data says
At $0.11, AVADEL PHARMACEUTICALS PLC's interest expense per share ranks #22 of 43 in the Health Care sector. Interest Expense per Share has fluctuated over the past 10 years, ranging from $0.00 in FY2015 to $0.33 in FY2019.
Based on SEC 10-K filings.
0.11 in FY2024 with a 5-year CAGR of -19.4%.
Improved from $0.21 to $0.11 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -12.5%
- 5-Year CAGR
- -19.4%
- 10-Year CAGR
- -
Sector benchmark
#22 of 43 in Health CareTop 49% of 43This company $0.11 Sector average $18.61
▼
-99.4% below sector average
Key checks
Key Insights
- In FY2024, interest expense per share decreased 7.7% year-over-year.
- Ranks #22 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2019.
- Lowest interest expense per share in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.11 | -7.7% |
| FY2023 | $0.12 | -40.0% |
| FY2022 | $0.21 | +20.9% |
| FY2021 | $0.17 | -28.2% |
| FY2020 | $0.24 | -29.1% |
| FY2019 | $0.33 | +17.3% |
| FY2018 | $0.28 | +1029.8% |
| FY2017 | $0.03 | +7.9% |
| FY2016 | $0.02 | - |
| FY2015 | $0.00 | -100.0% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026